Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promelaxin vs Macrogol 4000 in Pediatric Chronic Functional Constipation
NCT02751411Phase 4Completed
- Sponsor
- Aboca
- Start
- Apr 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic functional constipation (CIC) (2 arms), sponsored by Aboca. Primary endpoint: Improvement of constipation evaluated as a reduction of the typical symptoms of chronic functional constipation at 14 days. Started Apr 2016; status: completed.
02
Conditions
chronic functional constipation (CIC)
Beyond the preview
Go deeper on NCT02751411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02751411.